ZAP-70 enhances IgM signaling independent of its kinase activity in chronic lymphocytic leukemia

Blood

Volumn 111, Issue 5, 2008, Pages 2685-2692

  Chen, Liguang ^a,b   Huynh, Lang ^a,b   Apgar, John ^c   Tang, Li ^a,b   Rassenti, Laura ^a,b   Weiss, Arthur ^d   Kipps, Thomas J ^a,b  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b Chronic Lymphocytic Leukemia (CLL) Research Consortium   (United States)

^c BD Technologies   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE RECEPTOR; CBL PROTEIN; CD79B ANTIGEN; IMMUNOGLOBULIN F(AB')2 FRAGMENT; IMMUNOGLOBULIN M; PHOSPHOLIPASE C GAMMA; PROTEIN KINASE ZAP 70; PROTEIN P72; PROTEIN SH2; PROTEIN TYROSINE KINASE; B CELL LINKER PROTEIN; CD79 ANTIGEN; DNA; LYMPHOCYTE ANTIGEN RECEPTOR; MUTANT PROTEIN; SIGNAL TRANSDUCING ADAPTOR PROTEIN; UNCLASSIFIED DRUG; ZAP70 PROTEIN, HUMAN;

ARTICLE; CALCIUM MOBILIZATION; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; LEUKEMIA CELL; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; ADENOVIRUS; B CELL LEUKEMIA; B LYMPHOCYTE; CALCIUM SIGNALING; ENZYMOLOGY; GENETIC TRANSDUCTION; GENETIC TRANSFECTION; IMMUNOLOGY; PHOSPHORYLATION; PLASMID;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADENOVIRIDAE; ANTIGENS, CD79; B-LYMPHOCYTES; CALCIUM SIGNALING; DNA; HUMANS; IMMUNOGLOBULIN M; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; MUTANT PROTEINS; PHOSPHOLIPASE C GAMMA; PHOSPHORYLATION; PLASMIDS; RECEPTORS, ANTIGEN, B-CELL; SIGNAL TRANSDUCTION; TRANSDUCTION, GENETIC; TRANSFECTION; ZAP-70 PROTEIN-TYROSINE KINASE;

EID: 41949140313     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2006-12-062265     Document Type: Article

References (43)

1. Chan AC, Iwashima M, Turck CW, Weiss A. ZAP- 70: a 70 kd protein-tyrosine kinase that associates with the TCR zeta chain. Cell. 1992;71:649-662.
2. Chan AC, Irving BA, Fraser JD, Weiss A. The zeta chain is associated with a tyrosine kinase and upon T-cell antigen receptor stimulation associates with ZAP-70, a 70-kDa tyrosine phos-phoprotein. Proc Natl Acad Sci U SA. 1991;88: 9166-9170.
3. Qian D, Weiss A. T cell antigen receptor signal transduction. Curr Opin Cell Biol. 1997;9:205- 212.
4. Kane LP, Lin J, Weiss A. Signal transduction by the TCR tor antigen. Curr Opin Immunol. 2000; 12:242-249.
5. Chan AC, van Oers NS, Tran A, et al. Differential expression of ZAP-70 and Syk protein tyrosine kinases, and the role of this family of protein tyrosine kinases in TCR signaling. J Immunol. 1994;152:4758-4766.
6. Law CL, Sidorenko SP, Chandran KA, et al. Molecular cloning of human Syk: a B cell protein-tyrosine kinase associated with the surface immunoglobulin M-B cell receptor complex. J Biol Chem. 1994;269:12310-12319.
7. Taniguchi T, Kobayashi T, Kondo J, et al. Molecular cloning of a porcine gene syk that encodes a 72-kDa protein-tyrosine kinase showing high susceptibility to proteolysis. J Biol Chem. 1991;266: 15790-15796.
8. Chen L, Widhopf G, Huynh L, et al. Expression of ZAP-70 is associated with increased B-cell receptor signaling in chronic lymphocytic leukemia. Blood. 2002;100:4609-4614.
9. Rosenwald A, Alizadeh AA, Widhopf G, et al. Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia. J Exp Med. 2001; 194:1639- 1647.
10. Crespo M, Bosch F, Villamor N, et al. ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia. N Engl J Med. 2003;348:1764-1775.
11. Rassenti LZ, Huynh L,Toy TL, et al. ZAP-70 compared with immunoglobulin heavy-chain gene mutation status as a predictor of disease progression in chronic lymphocytic leukemia. N Engl J Med. 2004;351:893-901.
12. Zanotti R, Ambrosetti A, Lestani M, et al. ZAP-70 expression, as detected by immunohistochemistry on bone marrow biopsies from early-phase CLL patients, is a strong adverse prog nostic factor. Leukemia. 2007;21:102-109.
13. Chiorazzi N, Ferrarini M. B cell chronic lymphocytic leukemia: lessons learned from studies of the B cell antigen receptor. Annu Rev Immunol. 2003;21:841-894.
14. Kipps TJ. Immunoglobulin genes in chronic lymphocytic leukemia. Blood Cells. 1993;19:615- 625.
15. Richardson SJ, Matthews C, Catherwood MA, et al. ZAP-70 expression is associated with enhanced ability to respond to migratory and survival signals in B-cell chronic lymphocytic leukemia (B-CLL). Blood. 2006;107:3584-3592.
16. Gobessi S, Laurenti L, Longo PG, Sica S, Leone G, Etremov DG. ZAP-70 enhances B-cell- receptor signaling despite absent or inefficient tyrosine kinase activation in chronic lymphocytic leukemia and lymphoma B cells. Blood. 2007; 109:2032-2039.
17. Chen L, Apgar J, Huynh L, et al. ZAP-70 directly enhances IgM signaling in chronic lymphocytic leukemia. Blood. 2005;105:2036-2041.
18. Kong GH, Bu JY Kurosaki T, Shaw AS, Chan AC. Reconstitution of Syk function by the ZAP-70 protein tyrosine kinase. Immunity. 1995;2:485-492.
19. Semichon M, Merle-Beral H, Lang V, Bismuth G. Normal Syk protein level but abnormal tyrosine phosphorylation in B-CLL cells. Leukemia. 1997; 11:1921-1928.
20. Lanham S, Hamblin T, Oscier D, Ibbotson R, Stevenson F. Packham G. Differential signaling via surface IgM is associated with VH gene mutational status and CD38 expression in chronic lymphocytic leukemia. Blood. 2003;101:1087-1093.
21. Latour S, Chow LM, Veillette A. Differential intrinsic enzymatic activity of Syk and Zap-70 protein- tyrosine kinases. J Biol Chem. 1996;271:22782- 22790.
22. Zoller KE, MacNeil IA, Brugge JS. Protein tyrosine kinases Syk and ZAP-70 display distinct requirements for Src family kinases in immune response receptor signal transduction. J Immunol. 1997;158:1650-1659.
23. Fournel M, Davidson D, Weil R, Veillette A. Association of tyrosine protein kinase Zap-70 with the protooncogene product p120c-cbl in T lymphocytes. J Exp Med. 1996;183:301-306.
24. Lupher ML Jr, Rao N, Lill NL, et al. Cbl-mediated negative regulation of the Syk tyrosine kinase: a critical role for Cbl phosphotyrosine-binding domain binding to Syk phosphotyrosine 323. J Biol Chem. 1998;273:35273-35281.
25. Rao N, Ghosh AK, Ota S, et al. The non-receptor tyrosine kinase Syk is a target of Cbl-mediated ubiquitylation upon B-cell receptor stimulation. EMBO J. 2001;20:7085-7095.
26. Zhang Z, Elly C, Qiu L, Altman A, Liu YC. A direct interaction between the adaptor protein Cbl-b and the kinase zap-70 induces a positive signal in T cells. CurrBiol. 1999;9:203-206.
27. Ashe JM, Wiest DL, Abe R, Singer A. ZAP-70 protein promotes tyrosine phosphorylation of T cell receptor signaling motifs (ITAMs) in immature CD4(+)8(+) thymocytes with limiting p56(lck). J Exp Med. 1999;189:1163-1168.
28. Steinberg M, Adjali O, Swainson L, et al. T-cell receptor-induced phosphorylation of the zeta chain is efficiently promoted by ZAP-70 but not Syk. Blood. 2004;104:760-767.
29. Brdicka T, Kadlecek TA, Roose JP, Pastuszak AW, Weiss A. Intramolecular regulatory switch in ZAP-70: analogy with receptor tyrosine kinases. Mol Cell Biol. 2005;25:4924-4933.
30. Zhao Q, Weiss A. Enhancement of lymphocyte responsiveness by a gain-of-function mutation of ZAP-70. Mol Cell Biol. 1996;16:6765-6774.
31. Qian D, Mollenauer MN, Weiss A. Dominant- negative zeta-associated protein 70 inhibits T cell antigen receptor signaling. J Exp Med. 1996;183: 611-620.
32. Rao N, Lupher ML Jr, Ota S. Reedquist KA, Druker BJ, Band H. The linker phosphorylation site Tyr292 mediates the negative regulatory effect of Cbl on ZAP-70 in T cells. J Immunol. 2000; 164:4616-4626.
33. Panchamoorthy G, Fukazawa T, Miyake S, et al. p120cbl is a major substrate of tyrosine phosphorylation upon B cell antigen receptor stimulation and interacts in vivo with Fyn and Syk tyrosine kinases, Grb2 and She adaptors, and the p85 subunit of phosphatidylinositol 3-kinase. J Biol Chem. 1996;271:3187-3194.
34. Rao N, Dodge I, Band H. The Cbl family of ubiquitin ligases: critical negative regulators of tyrosine kinase signaling in the immune system. J Leukoc Biol. 2002;71:753-763.
35. Zomas AP, Matutes E, Morilla R, Owusu- Ankomah K, Seon BK, Catovsky D. Expression of the immunoglobulin-associated protein B29 in B cell disorders with the monoclonal antibody SN8 (CD79b). Leukemia. 1996;10:1966-1970.
36. Vuillier F. Dumas G. Magnac C, et al. Lower levels of surface B-cell-receptor expression in chronic lymphocytic leukemia are associated with glycosylation and folding defects of the mu and CD79a chains. Blood. 2005;105:2933-2940.
37. Cragg MS, Chan HT Fox MD, et al. The alternative transcript of CD79b is overexpressed in B- CLLand inhibits signaling for apoptosis. Blood. 2002;100:3068-3076.
38. Alfarano A, Indraccolo S, Circosta P, et al. An alternatively spliced form of CD79b gene may account for altered B-cell receptor expression in B-chronic lymphocytic leukemia. Blood. 1999;93: 2327-2335.
39. Allsup DJ, Kamiguti AS, Lin K, et al. B-cell receptor translocation to lipid rafts and associated signaling differ between prognostically important subgroups of chronic lymphocytic leukemia. Cancer Res. 2005;65:7328-7337.
40. \40. Deaglio S, Vaisitti T Aydin S, et al. CD38 and ZAP-70 are functionally linked and mark GLL cells with high migratory potential. Blood. 2007; 110:4012-4021.
41. Ian Mockridge C, Potter KN, Wheatley I, Neville LA, Packham G. Stevenson FK. Reversible anergy of slgM-mediated signaling in the two subsets of CLL defined by VH-gene mutational status. Blood. 2007;109:4424-4431.
42. Hamblin TJ. Predicting progression: ZAP-70 in CLL. N Engl J Med. 2004;351:856-857.
43. Castro JE, Prada CE, LoriaO, et al. ZAP-70 is a novel conditional heat shock protein 90 (Hsp90) client: inhibition of Hsp90 leads to ZAP-70 degradation, apoptosis, and impaired signaling in chronic lymphocytic leukemia. Blood. 2005;106: 2506-2512.